Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monopoly
Pharma
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win.
Fraiser Kansteiner
May 15, 2025 3:52pm
Viatris spared from EpiPen investor lawsuit in New York
Apr 3, 2023 10:40am
GSK sued over claims it built an asthma inhaler monopoly
May 25, 2022 3:12am
Sanofi puts Mylan's EpiPen pricing, rebates in crosshairs
Jun 2, 2021 11:01am
United illegally blocked generics to Remodulin, Sandoz suit says
Apr 18, 2019 7:05am
Sanofi claims Mylan abused EpiPen monopoly to quash rivals
Apr 25, 2017 10:07am
